Module 1: Inaugration: Dr B.K. Vashisht, State TB officer of Delhi inaugrated the session by lighting the lamp. He welcomed all the participants and the speakers. He highligted towards the challenges of DR TB regimen
Module 2: Newer initiatives and DRTB in India: Dr Sanjay Mattoo, Adl Deputy Director General, Central TB Division, Govt of India discussed about the Newer initiatives and DRTB, Key points of discussion were:
- Evolution of NTEP
- DR TB Management: in line with National strategic plan
- National Drug Resistant Survey (2014-16)
- Burden of TB (2022)
- NTEP Diagnostic Network
- India’s Progress in 2022 towards Ending TB Goals
- Drug-resistant Tuberculosis in India
- Current regimen and BPaLM/BPaL indication
- Consideration of newer drugs in children
- Strengthening India’s capacity for introducing advanced drugs and regimens
Module 3: Newer DR-TB Regimens: BPaL/M: Dr Pauline Howell, University of the Witwatersrand, Johannesburg, South Africa, discussed about South African Clinical BPaL Experience from Nix to roll-out, Key points of discussion were:
- South African Burden of Disease
- Programmatic Management of RR-TB
- Problems/challenges with DR-TB treatment?
- Drug resistant tuberculosis before 2016
- BPaL Regimens
- BPaL Clinical Access Programme
Module 4: Panel discussion: The Panel discussion was moderated by Dr Ashwini Khanna. The Panelist for the session were Dr BK Vashishat, Dr Sanjay Mattoo, Dr. Kuldeep Singh Sachdeva, Dr Rupak Singla, Dr Sangeeta Sharma, Dr. K.K. Chopra, Dr Virendra and Dr. Malik Parmar
Many questions were asked like:
- Modified BPal in India, current scenario
- BPal use in children
- Pill burden is inversly proportional to drug compliance... in that respect, BPal/M regime could have better outcome
- NIX trial, how long the post treatment follow up was followed?
Module 5: Vote of thanks: Vote of thanks was delivered by Dr Kanika, this was followed by felicitation
We wish you a great learning experience.
We thank Mylan Pharmaceuticals Private Limited, a Viatris Company for supporting us in the webinar.
Symposium inaugration: Dr B.K. Vashisht (2:00 pm - 2:10 pm)
Opening remarks: Dr B.K. Vashisht, Delhi State TB Office (2:20 pm - 2:30 pm)
Newer initiatives and DRTB in India: CTD official (2:30 pm - 2:50 pm)
International Speaker session by Dr. Pauline Howell (2:50 pm - 3:20 pm)
- Newer DR-TB Regimens: BPaL/M
- Outcomes from clinical trials and field operations research studies for BPaL/M
- Experience sharing from South Africa
Panel Discussion-Q&A (3:20 pm - 3:50 pm)
Speakers & Panelists: Dr. Pauline Howell, Dr Sanjay Mattoo, Dr B K Vashisht, Dr Ashwani Khanna, Dr Anuj Bhatnagar, Dr Rupak Singla, Dr K K Chopra
Vote of Thanks: Dr Kanika (3:50 pm - 4:00 pm)
